Valproic acid enhances pamidronate-sensitized cytotoxicity of Vδ2
Bisphosphonates
Epstein–Barr virus
PTLD
Valproic acid
Vδ2(+) T cells
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
01
07
2020
revised:
23
07
2020
accepted:
08
08
2020
pubmed:
21
8
2020
medline:
28
5
2021
entrez:
21
8
2020
Statut:
ppublish
Résumé
Therapeutic options for Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative diseases (PTLD) are currently limited, accompanying with some off-target toxicities. We previously demonstrated that early recovery of Vδ2
Identifiants
pubmed: 32818705
pii: S1567-5769(20)32192-5
doi: 10.1016/j.intimp.2020.106890
pii:
doi:
Substances chimiques
Valproic Acid
614OI1Z5WI
Pamidronate
OYY3447OMC
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106890Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare no potential conflicts of interest.